Illumina and big pharma join forces to create universal cancer test
This article was originally published in Scrip
Executive Summary
Gene sequencing company Illumina has signed a series of collaborative partnerships with major pharma companies to develop a universal next-generation sequencing (NGS)-based 'master' oncology test system.